Fate Accelerated public
[search 0]
More

Download the App!

show episodes
 
Loading …
show series
 
In today's quick episode, we talk about our new paper out now in JAMA Network Open titled "The Oncologic Drugs Advisory Committee Votes of April 2021—Implications for the Fate of Accelerated Approval"ODAC Votes: doi.org/10.1001/jamaoncol.2021.3046Back us on Patreon! www.patreon.com/plenarysessionCheck out our YouTube channel: www.youtube.com/channe…
 
Today we have two short monologues for you on recent papers. The first, by popular request, is the problems with the VISION trial, which treated metastatic castration-resistant prostate cancer with lutetium-177–PSMA-617 (Lu-177–PSMA-617) radioligand therapy and standard of care. The second is on the paper recently published in Science titled "Fecal…
 
Common Sense Networks CEO Eric Berger unveils Sensical, a new kid-centric app that gives parents peace of mind by offering a safe alternative to the bigger video platforms that have gotten a bad reputation for serving up algorithmically driven content that may not be in their best interest to watch. Learn more about your ad-choices at https://www.i…
 
CNN Worldwide chief digital officer Andrew Morse shares the game plan for what he calls the biggest launch in the network's history since Ted Turner first brought the brand to cable TV in 1980. He addresses what to expect from its programming mix, how CNN+ will be different from the TV network and how interactivity with subscribers will be part of …
 
Six months into 2021, and the profound financial impact the pandemic had on the media industry is just beginning to be truly understood. Naveen Sarma, senior director of S&P Global Ratings, has closely studied the myriad ways the sector has been shaken up. Learn more about your ad-choices at https://www.iheartpodcastnetwork.com…
 
We have a reverse episode for you today! Emma Greenstreet, a second-year medical student at UCSF, interviews our usual host, Dr. Vinay Prasad on why and how he chose hematology/oncology as a specialty, engaging with criticism, mentorship, medical student rotations, choosing a research project, and urging doctors in academia to aim higher. Back us o…
 
We sat down in person with Dr. Rahul Banerjee, a BMT/CAR-T fellow at UCSF, to talk about all manner of topics including CAR-T, randomized trials in oncology (and, specifically, Dr. Banerjee's two recent papers out now), social media, treating Multiple Myeloma, and how people make career decisions. What Oncologists Can Learn From COVID-19: doi.org/1…
 
The CEO and creative director of fashion juggernaut Alice + Olivia takes a break from the Allen & Co. moguls conference in Sun Valley to talk about the post-pandemic business landscape and why the ranks of female CEOS remain stubbornly low. Bendet Eisner also details her vision for Creatively, the startup professional network designed to help emplo…
 
Today we are joined by Dr. Ameet Sarpatwari of Harvard Medical School to discuss how so many great minds in oncology are leaving cancer research in academia for industry. We also talk about the evidence (or lack thereof) behind the recent FDA approval of aducanumab to treat Alzheimer's disease.Back us on Patreon! www.patreon.com/plenarysessionCheck…
 
Twitter execs Sarah Rosen and Lara Cohen break down how the company teams up with talent and media firms to maximize reach and engagement — while acknowledging work the social platform still needs to do. Learn more about your ad-choices at https://www.iheartpodcastnetwork.comBy iHeartRadio
 
Today we have a short monologue for you on just a few topics: a treatment algorithm for follicular lymphoma and our host Dr. Prasad's new paper out now in the European Journal of Clinical Investigation: "Reliable, cheap, fast and few: What is the best study for assessing medical practices? Randomized controlled trials or synthetic control arms?"RCT…
 
Thony and Casey decided to watch every episode of Hey Arnold! and make a podcast about it. These are their sleepover stories. The Gerald Field Report is created by Thony Moore and Casey Hills. Like all of our shows it can be found at semiautomagicinc.com and at @TheGFReport.By The Gerald Field Report
 
Scooter Braun’s business savvy and mentorship of top artists like Justin Bieber and Ariana Grande have netted him a fortune — but not without drama. Variety’s Music Mogul of the Year lays bare his management philosophy, addresses misconceptions about his character and reveals his future plans with South Korean entertainment giant HYBE. Learn more a…
 
Today we're back with another real-life (non-virtual!) interview. We're joined by Dr. Nina Shah of UCSF to discuss her career and her work in mutiple myeloma as well as the complexities of advancing your career -- dealing with productivity metrics like the h-index or the Kardashian index, switching institutions, balancing work with your home life, …
 
ViacomCBS' Seema Patel and Dish's Tim Myers go deep on addressable TV, and how businesses like theirs have partnered together to tackle the challenge of getting the industry to adopt the tools that enable targeted commercials. Learn more about your ad-choices at https://www.iheartpodcastnetwork.comBy iHeartRadio
 
Today we sit down with Dr. George Sledge of the Stanford University Medical Center to hear the story of his career and to discuss the history of breast cancer research and treatment.Back us on Patreon! www.patreon.com/plenarysessionCheck out our YouTube channel: www.youtube.com/channel/UCUibd0E2kdF9N9e-EmIbUew…
 
Today we're launching season 4 of Plenary Session! This season we're returning to our love of monologues. On today's episode we talk about highlights from the recent annual meeting of the American Society of Clinical Oncology. Back us on Patreon! www.patreon.com/plenarysessionCheck out our YouTube channel: www.youtube.com/channel/UCUibd0E2kdF9N9e-E…
 
Amounting to nearly $180 billion in 2020, the global video games market continues to ascend to new heights. Ophir Lupu, a partner and head of video games at UTA, discusses his involvement in several gaming sectors through his oversight of a diverse range of clients and negotiating of capital investment for new studios, along with how his division a…
 
On today's episode, we interview Dr. Marty Makary of Johns Hopkins School of Medicine and Bloomberg School of Public Health on how he chose his path in medicine, how health care as it is in the United States needs to change, and how groupthink dominated COVID-19 health policy. We discuss a variety of topics from his research on overuse, the prevale…
 
Today we have a brief monologue for you on how to think about COVID-19 policy in the context of rare event and declining probabilities. We also touch on what to expect from season 4 of this podcast, as season 3 comes to an end. Back us on Patreon! www.patreon.com/plenarysessionCheck out our YouTube channel: www.youtube.com/channel/UCUibd0E2kdF9N9e-…
 
Jane Rosenthal, founder and CEO of Tribeca Enterprises, offers her perspective on how the entertainment industry is slowly but surely coming back to life. She details the massive effort that went into planning for this year’s 20th anniversary Tribeca Film Festival across New York’s five boroughs. The film veteran also weighs in on the cyclical natu…
 
Today's episode is hosted by guest Logan Powell, an incoming medical student at the Texas A&M College of Medicine and creator of this podcast's show notes. He reverse interviews our usual host, Dr. Vinay Prasad, in honor of the one-year anniversary release of Dr. Prasad's book "Malignant: How Bad Policy and Bad Evidence Harm People with Cancer". Th…
 
Today we try something new. We're joined by five esteemed multiple myeloma experts for a back-and-forth round table discussion on the disease, including initial therapy, high risk, and maintenance. Our guests are Dr. Raj Chakraborty of Columbia University, Dr. Sam Rubinstein of the University of North Carolina Chapel Hill, Dr. Manni Mohyuddin of th…
 
Today we bring back our popular Journal Club with a Fellow segment. We're joined by Dr. Karine Tawagi of the Oschner Clinic in Louisiana to discuss the CLEAR trial: "Lenvatinib plus Pembrolizumab or Everolimus for Advanced Renal Cell Carcinoma" as published in the New England Journal of Medicine. CLEAR: doi.org/10.1056/NEJMoa2035716Back us on Patre…
 
Our guest today is Dr. Joshua Briscoe of Duke University. We discuss Med-Psych (a joint internal medicine and psychiatry residency) and how it and palliative care connect to the human side to medicine: providing the care for quality of life and dignity that patients actually need, from comfortable bedding to physician-assisted suicide.Back us on Pa…
 
We're joined today by Dr. Aaron Goodman, a hematologist/oncologist at the University of California San Diego, to discuss diffuse large B-cell lymphoma (DLBCL). We talk about bad cancer drugs and bad Twitter users.Back us on Patreon! www.patreon.com/plenarysessionCheck out our YouTube channel: www.youtube.com/channel/UCUibd0E2kdF9N9e-EmIbUew…
 
Loading …

Quick Reference Guide

Copyright 2021 | Sitemap | Privacy Policy | Terms of Service
Google login Twitter login Classic login